Seres Therapeutics, Inc.MCRBNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending higher, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-121.31M
↓ 14% below average
Average (9y)
$-106.02M
Historical baseline
Range
High:$-54.86M
Low:$-195.10M
CAGR
+9.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-121.31M | +37.8% |
| 2023 | $-195.10M | -8.4% |
| 2022 | $-179.91M | -179.0% |
| 2021 | $-64.49M | +26.8% |
| 2020 | $-88.13M | -22.6% |
| 2019 | $-71.88M | +28.3% |
| 2018 | $-100.28M | -9.7% |
| 2017 | $-91.39M | +1.6% |
| 2016 | $-92.84M | -69.2% |
| 2015 | $-54.86M | - |